In addition, since minimal residual disease (MRD) status has been pointed out in recent studies as a strong prognostic factor for relapse and DFS in AML, it would be interesting to analyze the correlation between PTK2B, LYN and PTK2 expression and MRD status in the future. This evidence concerns the gene PTK2B and acute myeloid leukemia.